MR Lymphangiography for Diagnosis of Lower Extremity Lymphedema: Suppressing Venous Signal Interference Using Deep Learning
Listen to this summary
The authors aimed to develop and evaluate LympClear, a deep learning-based method for suppressing venous signal interference in MR lymphangiography to improve the diagnosis of lower extremity lymphedema (LEL). Their results demonstrated that LympClear significantly enhanced image quality, increased the visibility of lymphatic reflux, and improved diagnostic efficiency compared to standard imaging techniques. Overall, the study indicates that LympClear is an effective tool for enhancing the diagnostic accuracy of MR lymphangiography in LEL patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Radiology
View all →Jun 23, 2026 · Radiology
Ten-year Longitudinal Relationship between Spinal Degenerative Lesions in Axial Spondyloarthritis at MRI and Radiography in the DESIR Cohort
Jun 23, 2026 · Radiology
Thrombectomy in Posterior Circulation Tandem Occlusions: Multicenter Comparative Analysis of Procedural Techniques and Predictors of Clinical Outcomes
Jun 23, 2026 · Radiology
Extending the PREVENT Equations with Cardiac MRI: Prediction of 10-year Heart Failure Risk
Jun 23, 2026 · Radiology
Standardized Knee Meniscus MRI Reporting: An Interdisciplinary Delphi Consensus
Jun 23, 2026 · Radiology
Longitudinal Analysis of Changes in Deep Learning Image-based Breast Cancer Risk Scores over Time
Jun 16, 2026 · Radiology
Radiology Reimagined: Interoperability and Lessons Learned from the Imaging AI in Practice Demonstration
More in Radiology
View all →Jun 24, 2026 · Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Point-of-Care Ultrasound M-Mode Analysis Using M.mode.ify: An External Validation Study for E-point Septal Separation Measurement
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · Journal of the American College of Radiology : JACR
ACR Appropriateness Criteria® Chronic Knee Pain: Update 2026
Jun 24, 2026 · JAMA
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial
Jun 24, 2026 · Journal of the American College of Radiology : JACR
ACR Appropriateness Criteria® Myelopathy: 2026 Update
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


